Science Explorer Back to mapMap
Discussion
Company · Winnipeg · Canada

Viventia Bio (Canada)

viventia.comROR OpenAlex
Research works
31
▼ 88% vs 2018-21
Citations
497
16.1 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
19%
world 40%
International
30%
world 18%
Viventia Bio (Canada)

Not ranked overall: Viventia Bio (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Viventia Bio (Canada) work in?

In all years, 55% of research at Viventia Bio (Canada) is in Life Sciences, 39% in Health Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (24%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 17 fractional works · 55.1% of its workBiochemistry, Genetics and Molecular Biology: 9 fractional works · 28.9% of its workBiotechnology: 5 fractional works · 15.1% of its workMolecular Biology: 4 fractional works · 12.2% of its workGenetics: 0 fractional works · 1.5% of its workImmunology and Microbiology: 7 fractional works · 23.8% of its workImmunology: 7 fractional works · 22.0% of its workVirology: 1 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 1.6% of its workPlant Science: 0 fractional works · 1.1% of its workFood Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workHealth Sciences: 12 fractional works · 39.0% of its workMedicine: 12 fractional works · 39.0% of its workRadiology, Nuclear Medicine and Imaging: 5 fractional works · 16.4% of its workOncology: 3 fractional works · 8.8% of its workSurgery: 1 fractional works · 3.5% of its workPathology and Forensic Medicine: 1 fractional works · 2.5% of its workNeurology: 0 fractional works · 1.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.1% of its workEmergency Medicine: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.2% of its workPhysical Sciences: 2 fractional works · 5.9% of its workEnvironmental Science: 1 fractional works · 3.8% of its workEcology: 1 fractional works · 3.8% of its workChemistry: 0 fractional works · 1.1% of its workSpectroscopy: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 0.7% of its workMechanical Engineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.2% of its workBiomaterials: 0 fractional works · 0.2% of its workALL ITS WORKViventia Bio(Canada)31fractional works, all years
Life Sciences55%Physical Sciences6%Health Sciences39%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology928.9%
    2. Immunology and Microbiology723.8%
    3. Agricultural and Biological Sciences01.6%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    5. Neuroscience00.2%
    1. Medicine1239.0%
    1. Environmental Science13.8%
    2. Chemistry01.1%
    3. Engineering00.7%
    4. Materials Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Viventia Bio (Canada)?

Ranked on the quality score, Jeannick Cizeau, Rachelle L. Dillon and Glen C. MacDonald lead among researchers whose main affiliation is Viventia Bio (Canada).

  1. 1 Jeannick Cizeau Canada · #938,731 worldwide 2.8k citations · 39 works
  2. 2 Rachelle L. Dillon Canada · #1,388,316 worldwide 1.1k citations · 57 works
  3. 3 Glen C. MacDonald Canada · #1,687,559 worldwide 1.3k citations · 43 works
  4. 4 Joycelyn Entwistle Canada · #2,476,758 worldwide 1.1k citations · 24 works
  5. 5 Nick Glover Canada · #2,761,984 worldwide 244 citations · 20 works
All ranked researchers at Viventia Bio (Canada)

What are the most cited papers from Viventia Bio (Canada)?

The most cited paper from Viventia Bio (Canada) is "A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin" (Mark Marion Kowalski, Jacinthe Guindon, Louise Brazas et al., 2012), with 122 citations. Next come "Optimal Design Features of Camelized Human Single-domain Antibody Libraries" (79) and "Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin" (79).

Most cited papers
#PaperReleasedCitations
1 A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin Mark Marion Kowalski, Jacinthe Guindon, Louise Brazas et al. · The Journal of Urology 19 Sep 2012 122
2 Optimal Design Features of Camelized Human Single-domain Antibody Libraries Jamshid Tanha, Ping Xu, Zhigang Chen et al. · Journal of Biological Chemistry Open access 2001 79
3 Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin Jeannick Cizeau, Danielle M. Grenkow, Jennifer G. Brown et al. · Journal of Immunotherapy 18 Jun 2009 79
4 A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients Macdonald, Mark Marion Kowalski, J. Entwistle et al. · Drug Design Development and Therapy Open access Nov 2010 72
5 Rabies Control in Wild Carnivores Richard C. Rosatte, Rowland R. Tinline, David H. Johnston · Elsevier eBooks Book chapter 2007 48
All 39 most cited papers, with filters and sorting

Which keywords describe research at Viventia Bio (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Glycosylation, Targeted Therapy, Immunotoxin, Ricin Poisoning, Monoclonal Antibodies, Therapeutic Antibodies and Antibody Engineering.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Cancer Therapy7▲ 34×4 topics
  2. Glycosylation6▲ 91×3 topics
  3. Targeted Therapy6▲ 93×2 topics
  4. Immunotoxin6▲ 624×1 topic
  5. Ricin Poisoning6▲ 624×1 topic
  6. Monoclonal Antibodies5▲ 119×2 topics
  7. Therapeutic Antibodies5▲ 133×2 topics
  8. Antibody Engineering5▲ 162×1 topic
  9. Fc Receptors5▲ 162×1 topic
  10. Immunotherapy4▲ 19×7 topics
  11. Biopharmaceuticals3▲ 140×2 topics
  12. Recombinant Proteins3▲ 179×2 topics
  13. Plant Molecular Farming3▲ 354×1 topic
  14. Vaccine Antigens3▲ 354×1 topic
  15. Cancer3▲ 5.9×8 topics
  16. Tumor Regression2▲ 94×2 topics
  17. Gene Therapy2▲ 24×2 topics
  18. Tumor Targeting2▲ 44×3 topics
  19. Arginine Deprivation2▲ 123×1 topic
  20. Bacterial Therapy2▲ 123×1 topic
  21. Chemotherapy2▲ 7.2×4 topics
  22. Genomics1▲ 12×2 topics
  23. Virus1▲ 36×2 topics
  24. Cancer Immunotherapy1▲ 27×2 topics
  25. Microbiome1▲ 26×2 topics
  26. Nanoparticles1▲ 3.0×4 topics
  27. Therapy1▲ 18×2 topics
  28. Glycans1▲ 44×1 topic
  29. Immune System1▲ 11×1 topic
  30. Bacteriophage1▲ 49×1 topic
  31. Ecology1▲ 16×1 topic

Which research topics does Viventia Bio (Canada) publish most on?

By volume in 2022-now: Plant and Biological Electrophysiology Studies, Smart Agriculture and AI and Tree Root and Stability Studies.

Plant and Biological Ele…0Plant and Biological Electrophysiology Studies: 0 fractional worksSmart Agriculture and AI0Smart Agriculture and AI: 0 fractional worksTree Root and Stability …0Tree Root and Stability Studies: 0 fractional works
Plant ScienceMechanical Engineering

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Plant and Biological Electrophysiology Studies Plant Science 0 works
  2. 2 Smart Agriculture and AI Plant Science 0 works
  3. 3 Tree Root and Stability Studies Mechanical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.7%not open81.3%

World: 40% of research is openly available.

with international co-authors30.5%domestic only69.5%

World: 18% is written across borders.

How has Viventia Bio (Canada)'s research output changed?

Output in 2022-2025 was 88% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Viventia Bio (Canada) as a percentage of every work published that year, 0.000029% in 2021.

still counting0.00010%0.00020%0.00030%Viventia Bio (Canada)0.0000085% in 202520102020

Fractional works of Viventia Bio (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Winnipeg

All research institutions in Winnipeg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Viventia Bio (Canada). Posts are plain text and can be reported.